COVID-19 in a patient receiving adjuvant breast cancer chemotherapy with granulocyte olony-stimulating factor (G-CSF) support: A case report

Patients receiving chemotherapy are at high risk for severe infections and complications such as acute respiratory syndrome. The most commonly used adjuvant chemotherapy protocols (docetaxel-cyclophosphamide every 3 weeks or the dose-dense regimen, doxorubicin-cyclophosphamide every 2 weeks followed...

Descripción completa

Detalles Bibliográficos
Autores principales: Yerushalmi, Rinat, Sagi, Moshe, Goldvaser, Hadar, Daliot, Jonathan, Mutai, Raz, Krause, Ilan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060854/
https://www.ncbi.nlm.nih.gov/pubmed/33903823
http://dx.doi.org/10.3892/mco.2021.2279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060854/
https://www.ncbi.nlm.nih.gov/pubmed/33903823
http://dx.doi.org/10.3892/mco.2021.2279

Ejemplares similares